日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic analysis and expression patterns of programmed cell death ligand 1 and BRAF V600E in esophageal neuroendocrine carcinoma.

食管神经内分泌癌中程序性死亡配体 1 和 BRAF V600E 的预后分析及表达模式。

Zhang Chengcheng, Zheng Li, Xu Binwen, Shi Guidong, Fu Maoyong

Clinical efficacy of different therapeutic strategies in patients with spontaneous rupture of the esophagus: a multicenter retrospective cohort study

不同治疗策略在自发性食管破裂患者中的临床疗效:一项多中心回顾性队列研究

Luan, Siyuan; Xiao, Xin; Zeng, Xiaoxi; Ren, Jie; Liu, Wen; Luo, Jiwen; Mei, Xinyu; Zhou, Xinpeng; Li, Rulin; Deng, Yufeng; Fu, Maoyong; Shi, Guidong; Du, Shijian; Wu, Yunhua; Li, Chong; Wang, Yuncang; Li, Gang; Yang, Changjie; Zhou, Jianfeng; Mao, Chengyi; Hu, Weipeng; Chen, Longqi; Yang, Yushang; Yuan, Yong

Impact of skeletal muscle loss and sarcopenia on outcomes of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma

骨骼肌丢失和肌少症对食管鳞状细胞癌新辅助免疫化疗疗效的影响

Xu, Binwen; Liu, Junhong; Zhang, Yue; Luo, Tao; Xiong, Jie; Wang, Hanxiao; Shi, Guidong; Fu, Maoyong

Peripheral blood cells predict the efficacy and prognosis of neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma

外周血细胞可预测新辅助免疫疗法联合化疗治疗食管鳞状细胞癌的疗效和预后

Ran, Xingqiang; Zhang, Chengcheng; Zheng, Li; Luo, Tao; Xu, Binwen; Zhang, Yue; Zhang, Liwen; Yang, Bo; Fu, Maoyong

Analysis of the safety and efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy in the treatment of locally advanced resectable esophageal squamous cell carcinoma: a systematic review and meta-analysis based on four randomized controlled trials

PD-1/PD-L1抑制剂联合化疗治疗局部晚期可切除食管鳞状细胞癌的安全性和有效性分析:基于四项随机对照试验的系统评价和荟萃分析

Luo, Tao; Yang, Hao; Ran, Xingqiang; Xu, Binwen; Zhang, Yue; Zhang, Liwen; Zhang, Chengcheng; Fu, Maoyong

Pathological complete response to conversion therapy for lung adenocarcinoma with brain metastasis: a case report

肺腺癌脑转移患者经转化治疗后病理完全缓解:病例报告

Ran, Xingqiang; Luo, Tao; Xiong, Jie; Fu, Maoyong

Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma

pN+浅表食管鳞状细胞癌的淋巴结转移

Yang, Yafan; Xue, Liyan; Chen, Xiankai; Kang, Mingqiang; Zhang, Renquan; Tian, Hui; Ma, Jianqun; Fu, Maoyong; Wei, Jinchang; Liu, Qi; Hao, Anlin; He, Yi; Zhang, Ruixiang; Xie, Hounai; Xu, Lei; Luo, Peng; Qin, Jianjun; Li, Yin

The Duration of Prophylactic Antibiotic Use for Esophageal Cancer Patients with Postoperative Infection and Nutritional Status

食管癌术后感染患者预防性抗生素使用时长及营养状况

Ning, Dong; Zhou, Lin; Shi, Guidong; Fu, Maoyong

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

可切除食管鳞状细胞癌新辅助化疗联合或不联合卡瑞利珠单抗:随机3期ESCORT-NEO/NCCES01试验

Qin, Jianjun; Xue, Liyan; Hao, Anlin; Guo, Xiaofeng; Jiang, Tao; Ni, Yunfeng; Liu, Shuoyan; Chen, Yujie; Jiang, Hongjing; Zhang, Chen; Kang, Mingqiang; Lin, Jihong; Li, Hecheng; Li, Chengqiang; Tian, Hui; Li, Lin; Fu, Junke; Zhang, Yong; Ma, Jianqun; Wang, Xiaoyuan; Fu, Maoyong; Yang, Hao; Yang, Zhaoyang; Han, Yongtao; Chen, Longqi; Tan, Lijie; Dai, Tianyang; Liao, Yongde; Zhang, Weiguo; Li, Bin; Chen, Qixun; Guo, Shiping; Qi, Yu; Wei, Li; Li, Zhigang; Tian, Ziqiang; Kang, Xiaozheng; Zhang, Ruixiang; Li, Yong; Wang, Zhen; Chen, Xiankai; Hou, Zhiguo; Zheng, Rongrong; Zhu, Wenqing; He, Jie; Li, Yin

Clinical outcomes of conversion surgery after induction immunochemotherapy for borderline resectable T4 esophageal squamous cell carcinoma

临界可切除T4期食管鳞状细胞癌诱导免疫化疗后转换手术的临床结果

Zhang, Chengcheng; Xu, Binwen; Luo, Tao; Zhang, Yue; Zhang, Liwen; Shi, Guidong; Fu, Maoyong